Difficulty: Medium
Average Score: 95%
Practice
Ranitidine is a new histamine receptor blocker. It is
Correct answer
C
Rationale
Ranitidine is a well-known histamine H2 receptor antagonist that is used to reduce stomach acid production. The correct answer is C) More potent, competitive, and selective antagonist of histamine at the gastric site. This is because ranitidine competitively blocks the H2 receptors in the stomach, leading to decreased acid secretion.
Option A is incorrect because ranitidine is actually more potent than cimetidine and acts as a competitive antagonist. Option B is incorrect as ranitidine is not the most toxic histamine antagonist and is generally well-tolerated. Option D is incorrect as we have established that option C is the correct answer.
Educationally, understanding the mechanism of action of gastrointestinal drugs like ranitidine is crucial for healthcare professionals to make informed decisions in patient care. Knowing the specific characteristics of ranitidine compared to other drugs in the same class helps in prescribing the most suitable medication for individual patients based on their condition and tolerance levels. This knowledge also aids in preventing adverse drug reactions and optimizing treatment outcomes.
Option A is incorrect because ranitidine is actually more potent than cimetidine and acts as a competitive antagonist. Option B is incorrect as ranitidine is not the most toxic histamine antagonist and is generally well-tolerated. Option D is incorrect as we have established that option C is the correct answer.
Educationally, understanding the mechanism of action of gastrointestinal drugs like ranitidine is crucial for healthcare professionals to make informed decisions in patient care. Knowing the specific characteristics of ranitidine compared to other drugs in the same class helps in prescribing the most suitable medication for individual patients based on their condition and tolerance levels. This knowledge also aids in preventing adverse drug reactions and optimizing treatment outcomes.